ReviewPharmaceutics2021

Considerations in the Design of Non-Clinical Development Programmes to Support Non-Viral Genetically Modified Mesenchymal Stromal Cell Therapies.

Valeria Iansante et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.